This study is completed in France, in the United Kingdom, in Croatia, .... It is testing Transition to the Paliperidone Palmitate 3-Month Formulation for schizophrenia.
In France
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 50 Years
This study is completed in France, in the United Kingdom, in Switzerland, .... It is testing Effectiveness and Safety of Prolonged Release OROS Methylphenidate for ADHD.
This study is completed in the United States, in France, in Bulgaria, .... It is testing Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo for Bipolarity.
In France
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, France, Bulgaria, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
This study is completed. It focuses on ADHD and currently lists study information in Austria, Belgium, France, Germany, Ireland, Italy, the Netherlands, Poland, Romania, Spain, Sweden, Ukraine, and the United Kingdom.
This study is enrolling by invitation. It focuses on schizophrenia and currently lists participation information in Brazil, Bulgaria, Chile, Czech Republic, France, Italy, Mexico, Serbia, South Korea, Spain, Taiwan, and the United States.
This study is completed in France, in the United Kingdom, in Switzerland, .... It is testing Flexibly Dosed Paliperidone Extended Release (ER) for schizophrenia.